The delivery of healthcare at home is growing fast. Covering everything from the hospital at home concept through to palliative care and to the treatment of almost every chronic disease, the sector is growing by 20% per annum in revenue in many European countries.

There are several factors behind this. Firstly, many patients prefer to be treated at home, secondly, medicalised homecare is 3-10 times cheaper than inpatient care and, thirdly, new technologies from infusion pumps through to telehealthcare make homecare a viable alternative for an increasing wide range of conditions.

Increasingly, it is a field dominated by a plethora of private players ranging from industrial gas companies, nursing specialists, pharma and medtech distributors through to vertically integrated pharma and medtech companies.

Opportunities in Healthcare: The Medical Homecare Market in Europe is the first to look at the homecare business model and how it is developing across Europe. As such, it covers sectors and companies delivering respiration, dialysis, parenteral nutrition, wound/stoma care, infusion therapy, chemotherapy, telehealthcare or simply the delivery and administration of drugs and medtech products.

Most specialists in the homecare field are immersed in their particular segment or business model. For the first time ever, this report gives the reader a clear picture of who is delivering what across 13 different European countries, ranging from Portugal to Poland and from Italy to Sweden. It also provides detailed estimates and forecasts for the different segments making up the homecare market. It also analyses different and innovative business models.

Crucially, it also looks at payor regimes and how they are changing.

It answers such questions as: Who are the private operators and what are their business strategies? How large are the opportunities? How will payor regimes change?

Based on primary research - interviews with 200 entrepreneurs and policymakers - the 230 page report provides a comprehensive overview of each sector and detailed reports on no fewer than 13 different national markets, including data on national market sizes and forecast growth rates. It also includes profiles of the top players and analyses profit margins.

The report is vital reading for anyone who is looking to invest or expand their operations in Europe. It enables you to:

• Save months of time and tens of thousands of euros on research
• Size national markets, likely growth rates and prices
• Identify all significant players
• Assess which markets will be the most interesting going forwards
• Analyse your competitors

The report is a must read for:

• Pharma and medtech companies 
• Homecare operators
• Policymakers
• Investors 
• Advisers 
• Telehealth solution and other IT suppliers 
• Pharma distributors 
• Medtech distributors

Here is what buyers of our existing reports say:

Joe Ryan, chief financial officer, Medicover: "Very good indeed. A lot of insights on different national markets. Most unusually, this report really tells it as it is. It gives you the reality something that frightens many people in this industry. Well worth the money."

David Low, Analyst, Deutschebank: "The market sizing data is particularly useful. It gives a clear picture of what is happening at country level across Europe. Well worth the money."

Marten Hardens, SVP, Labco: "An extremely useful report with a lot of accurate data and information. In particular the coverage of the larger groups is pretty comprehensive."

The report, published in March 2012, costs £2,500 for hard copy and £3,000 for a pdf site licence for use across the company.





For more information contact Healthcare Europa on 44 207 183 3779
or contact Max Hotopf at max@healthcareeuropa.com